"Papanicolaou Test" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cytological preparation of cells collected from a mucosal surface and stained with Papanicolaou stain.
- Papanicolaou Test
- Test, Papanicolaou
- Pap Test
- Test, Pap
- Pap Smear
- Smear, Pap
- Papanicolaou Smear
- Smear, Papanicolaou
Below are MeSH descriptors whose meaning is more general than "Papanicolaou Test".
Below are MeSH descriptors whose meaning is more specific than "Papanicolaou Test".
This graph shows the total number of publications written about "Papanicolaou Test" by people in this website by year, and whether "Papanicolaou Test" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Papanicolaou Test" by people in Profiles.
Ersoy E, Kashikar RM. Psammoma bodies in Papanicolaou tests and associated factors to predict an underlying malignancy: a clinicopathological analysis of 10 cases. J Am Soc Cytopathol. 2020 Jul - Aug; 9(4):266-271.
Peitzmeier SM, Bernstein IM, McDowell MJ, Pardee DJ, Ag?nor M, Alizaga NM, Reisner SL, Potter J. Enacting power and constructing gender in cervical cancer screening encounters between transmasculine patients and health care providers. Cult Health Sex. 2020 12; 22(12):1315-1332.
Brousseau EC, Ahn S, Matteson KA. Cervical Cancer Screening Access, Outcomes, and Prevalence of Dysplasia in Correctional Facilities: A Systematic Review. J Womens Health (Larchmt). 2019 12; 28(12):1661-1669.
Hallett LD, Gerber MR. Human Papillomavirus Testing by Veterans Administration Women's Health Providers: Are They Adhering to Guidelines? J Womens Health (Larchmt). 2018 02; 27(2):179-182.
Peitzmeier SM, Ag?nor M, Bernstein IM, McDowell M, Alizaga NM, Reisner SL, Pardee DJ, Potter J. "It Can Promote an Existential Crisis": Factors Influencing Pap Test Acceptability and Utilization Among Transmasculine Individuals. Qual Health Res. 2017 Dec; 27(14):2138-2149.
Habbema D, Weinmann S, Arbyn M, Kamineni A, Williams AE, M C M de Kok I, van Kemenade F, Field TS, van Rosmalen J, Brown ML. Harms of cervical cancer screening in the United States and the Netherlands. Int J Cancer. 2017 Mar 01; 140(5):1215-1222.
Magnani B, Harubin B, Katz JF, Zuckerman AL, Strohsnitter WC. See, Test & Treat: A 5-Year Experience of Pathologists Driving Cervical and Breast Cancer Screening to Underserved and Underinsured Populations. Arch Pathol Lab Med. 2016 Dec; 140(12):1411-1422.
Wittenberg E, Bharel M, Bridges JF, Ward Z, Weinreb L. Using Best-Worst Scaling to Understand Patient Priorities: A Case Example of Papanicolaou Tests for Homeless Women. Ann Fam Med. 2016 07; 14(4):359-64.
Ag?nor M, Peitzmeier SM, Bernstein IM, McDowell M, Alizaga NM, Reisner SL, Pardee DJ, Potter J. Perceptions of cervical cancer risk and screening among transmasculine individuals: patient and provider perspectives. Cult Health Sex. 2016 10; 18(10):1192-206.
Troisi R, Hatch EE, Palmer JR, Titus L, Robboy SJ, Strohsnitter WC, Herbst AL, Adam E, Hyer M, Hoover RN. Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract. Am J Obstet Gynecol. 2016 09; 215(3):322.e1-8.